# Planning and Evaluation

> **NIH NIH P30** · WAKE FOREST UNIVERSITY HEALTH SCIENCES · 2020 · $16,272

## Abstract

PLANNING AND EVALUATION 
Project Summary 
Planning and Evaluation supports the scientific and administrative evaluation and strategic planning of all 
major initiatives at the Wake Forest Baptist Comprehensive Cancer Center (WFBCCC). The leadership of the 
WFBCCC uses both internal and external committees and boards to obtain substantive advice to inform the 
decision-making process and continuously develop and modify the plans of the Center. The WFBCCC 
Director, Boris Pasche, M.D., Ph.D., has strategically enhanced the WFBCCC's leadership as follows: 
 ● The Senior Leadership Committee meets weekly to discuss and evaluate the day-to-day strategic 
 planning initiatives and is comprised of the Director, Deputy Director, Associate Directors, Program 
 Leaders and Co-Leaders, and the Director of Finance. 
 ● The Internal Advisory Board meets monthly to provide the primary decision-making for the WFBCCC 
 and is comprised of the Director, Deputy Director, Associate Directors, Program Leaders, a multi- 
 disciplinary group of leaders chosen for their leadership and advocacy in the WFBCCC, and key 
 administrative staff members. 
 ● The Institutional Executive Advisory Committee, chaired by the Dean of the School of Medicine, is 
 comprised of leaders and representatives of other Centers from Wake Forest Baptist Medical Center, 
 Wake Forest University (undergraduate and graduate school campus), and the joint Virginia Tech-Wake 
 Forest University School of Biomedical Engineering and Sciences. In these quarterly meetings, the 
 WFBCCC Director advocates for the Center and promotes interactions on issues pertaining to 
 institutional commitment, recruitment, alignment of strategic priorities, new research collaborations, and 
 opportunities to support Institution-wide research initiatives. 
 ● The External Advisory Board is comprised of external advisors who are directors, senior researchers, 
 and administrative leaders from other NCI-designated Centers and has provided invaluable feedback to 
 the WFBCCC. The Board was expanded in 2014 and 2015 after Dr. Pasche became the WFBCCC 
 Director. The EAB now has 12 members, 3 of whom have served previously, 
These various advisory group meetings – in conjunction with membership retreats, Shared Resource quarterly 
meetings, and ad hoc external advisory meetings – have helped the WFBCCC develop a new five-year 
strategic plan, enhance scientific expertise through targeted recruitment, expand Shared Resources to address 
the changing needs of investigators, form new collaborations among investigators on important topics (e.g. 
cognition and cancer, genomics, biomedical engineering), and strengthen the overall institutional support and 
commitment to the WFBCCC.

## Key facts

- **NIH application ID:** 9848528
- **Project number:** 5P30CA012197-45
- **Recipient organization:** WAKE FOREST UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** Boris Pasche
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $16,272
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9848528

## Citation

> US National Institutes of Health, RePORTER application 9848528, Planning and Evaluation (5P30CA012197-45). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9848528. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*